Information Request Form

Section:	Main.NEUROLOGY..Multiple Sclerosis.Treatment.Paclitaxel..Patent..Claims.Claim 1: Multiple Sclerosis Treat..Method. Adm. to Patient Paclitaxel..Claim 2: Systemic Adm. Claim 3:.Oral or IntraVenous Adm. Claim 4:.Dosage: 10-75 mg/m.sup.2 Once.Every 1-4 Weeks. Claim 5: Polymer..Claim 6: Compn Form: MicroSpheres.Claim 7: Lactic Acid/Glycolic Acid.CoPol. Claim 8: Poly(Caprolactone)..Claim 9: Poly(Lactic Acid). Claim.10: Caprolactone/Lactic Acid CoPol..Claim 11: PolyEthylene Glycol..Claim 12: Ethylene/Vinyl Acetate.CoPol. Claim 13: Paclitaxel Compn.& Iso-Pr Myristate. Claim 14:.Paclitaxel Compn & Glycol. Claim 15.: Glycol: EthoxyDiGlycol. Claims 19.,20,21: Paclitaxel Dose=25,50 & 75.mg/m.sup.2 resp. Claim 21:.Paclitaxel Infused for=1-2 hours..Claim 22: PreMedication:.HydroCortisone. Claim 23: PreMed.:.Di-Ph-Hydramine & Cimetidine or.Ranitidine. Patent Assignee
Code:	57669
Product:	Canada. A
Company or Organization:
Contact's name *:
Position:
E-mail:
Mailing address:
Phone number:
Fax number:
Fields of interest:	PATENT ASSIGNEE PATENT INVENTORS PATENT NUMBER PATENT PARENT CASE TEXT
* If you are not linked to any company or organization complete at least this field